Cutia Therapeutics says NMPA accepted biologics license application
Cutia Therapeutics (HKEX:2487) said China’s NMPA accepted its biologics license application for CU-20101.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.